Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...
BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...
FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...
The first shipment of 1.2 million SARS-CoV-2 Assays for use on the BD Veritor™ Plus System to be delivered in The Netherlands by mid-November For Product Enquiries and How to Order:All BD SARS-CoV-2 ...
The test is based on the company's BD Veritor Plus System, a handheld diagnostic device. The test is used in combination with the company's BD Veritor Plus System, a handheld electronic diagnostic ...
Becton, Dickinson and Company BDX, popularly known as BD, received emergency use authorization (“EUA”) from the FDA for a new, rapid antigen test, which can simultaneously identify SARS-CoV-2, ...
The new test reportedly delivers results in approximately 15 minutes on a portable instrument MISSISSAUGA, Ont. — BD (Becton, Dickinson and Company), a medical technology company, announced its rapid, ...
BD VERITOR SYSTEM FOR RAPID DETECTION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) kit by BD Diagnostics BD Diagnostics announced that it has received clearance from the FDA for nasopharyngeal wash, aspirate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback